| Literature DB >> 33354411 |
Jonas Nielsen1, Casper Glissmann Nim2,3, Søren O'Neill2,3, Eleanor Boyle4, Jan Hartvigsen1,4, Gregory N Kawchuk1,5.
Abstract
BACKGROUND: Objectively measured reduction in lumbar posterior-to-anterior (PA) stiffness is associated with pain relief in some, but not all persons with low back pain. Unfortunately, these measurements can be time consuming to perform. In comparison, the Lumbar Spine Instability Questionnaire (LSIQ) is intended to measure spinal instability and the Lumbar Spine Disability Index (LSDI) is created for self-reporting functional disability due to increased spinal stiffness. Given the above, the aim of this study is to compare measures of the LSIQ and LSDI with objective measures of lumbar PA stiffness as measured by a mechanical device, Vertetrack (VT), in patients with persistent non-specific low back pain (nsLBP).Entities:
Keywords: LBP; LSDI; LSIQ; Low back pain; Lumbar spine instability questionnaire; Lumbar stiffness disability index; P-A spinal stiffness measures; Self-reports; Spinal stiffness; Vertetrack
Year: 2020 PMID: 33354411 PMCID: PMC7727369 DOI: 10.7717/peerj.9598
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
Inclusion & exclusion criteria.
| ∘ Fulfil informed written consent. |
| ∘ Have the ability to speak and read Danish. |
| ∘ Be between the age of 18 and 60. |
| ∘ Have a body mass index <35 |
| ∘ Have had LBP >3 months, defined as pain on the posterior aspect of the body between the 12th thoracic vertebrae and the gluteal folds. |
| ∘ Have no previous back surgery and not have had surgery in general in the last 4 months. |
| ∘ Have received no spinal manipulation in the last month. |
| ∘ Take no other pain medication than paracetamol, NSAIDs or weak synthetic opioids |
| ∘ Have no competing diagnoses which could |
| (a) confound the diagnosis of nsLBP e.g., osteoporosis, cancer, fibromyalgia etc. |
| (b) interfere with the allocated treatment |
| ∘ Were not completing the allocated intervention (minimum 75% of scheduled treatments). |
| ∘ Did not fill out the questionnaires |
| ∘ Received other treatment than that administered as part of the study. |
| ∘ Deviated from the agreed upon medication at baseline measures within the treatment period. |
| ∘ Were unable to hold breath for 10 s. |
Figure 1Lumbar Spine Instabilité Questionnaire (LSIQ).
Figure 2Lumbar Spine Disability Index (LSDI).
Figure 3The Vertetrack with contact rollers and trajectory points.
Figure 4Study flow chart.
Figure 5Force-displacement curve (A–B).
Each point indicates added mass. (B) is a smoothed version of A. Raw data (A) was used to calculate the SS-scores.
Clinical characteristics collected from the Spine Data questionnaire.
| Mean (SD) | |
|---|---|
| Age (years) | 44.9 (9.9) |
| Male | 22 |
| Female | 13 |
| Duration of back pain (years) | 5.2 (9.2) |
| Baseline back pain (NRS) | 5.6 (2.0) |
Figure 6Scatterplots of linear relationships.
(A) and (B) Relation between baseline LSIQ/LSDI scores and mean baseline stiffness score (N/mm). (C) and (D) Relation between LSIQ/LSDI change scores and stiffness change scores.
Results.
LSIQ, LSDI and VT data (baseline, follow-up and change scores). Number of responders and non-responders including mean percentage change score following intervention.
| Baseline | Follow-up | Change score | # Responders | # Non-responders | |
|---|---|---|---|---|---|
| LSIQ | 10.4 ± 1.7 | 9.1 ± 2.2 | −1.3 ± 2.2 (0.003) | 21 (−22.5) | 8 (17.1) |
| LSDI | 32.3 ± 11.0 | 27.8 ± 11.0 | −4.5 ± 9.6 (0.018) | 14 (−33.5) | 15 (11.4) |
| VT(N/mm): | |||||
| L1 | 4.48 ± 0.96 | 4.48 ± 0.84 | 0.004 ± 0.73 (0.977) | 10 (−15) | 19 (10) |
| L2 | 4.50 ± 0.99 | 4.52 ± 0.84 | 0.025 ± 0.73 (0.854) | 7 (−17.7) | 22 (8.5) |
| L3 | 4.52 ± 0.93 | 4.57 ± 0.84 | 0.052 ± 0.59 (0.640) | 9 (−12.5) | 20 (8.7) |
| L4 | 4.63 ± 0.95 | 4.67 ± 0.84 | 0.042 ± 0.60 (0.711) | 8 (−13.5) | 21 (7.8) |
| L5 | 4.90 ± 0.99 | 4.92 ± 0.89 | 0.020 ± 0.68 (0.874) | 10 (−12.8) | 19 (9.2) |
| TLS | 4.60 ± 0.91 | 4.63 ± 0.81 | 0.029 ± 0.58 (0.794) | 7 (−14.7) | 22 (6.7) |
Results.
Correlation between LSDI and SS/MLS, both at baseline and for the change scores. Welch two-sample t-test and chi-square test for association between responders/non-responders (see “data analysis”.
| Spearman: | Spearman: change score | Welch: t-score | Chi-squared | |
|---|---|---|---|---|
| LSIQ: | ||||
| L1 | −0.08 (0.6634) | −0.16 (0.3964) | 0.1081 (0.916) | 0.04452 (0.8329) |
| L2 | −0.12 (0.5226) | −0.14 (0.4695) | 0.3500 (0.733) | 0.00448 (0.9466) |
| L3 | −0.15 (0.4443) | −0.07 (0.7026) | 0.6307 (0.542) | 0.21577 (0.6423) |
| L4 | −0.12 (0.5319) | 0.00 (0.9928) | 0.8098 (0.434) | 0.54350 (0.4610) |
| L5 | −0.14 (0.4545) | −0.09 (0.6267) | 0.9746 (0.347) | 3.83900 (0.0501) |
| MLS | −0.17 (0.3736) | −0.06 (0.7578) | 0.6106 (0.554) | 0.00087 (0.9764) |
| LSDI: | ||||
| L1 | −0.07 (0.7078) | −0.08 (0.6812) | 0.5003 (0.621) | 0.84020 (0.3593) |
| L2 | −0.15 (0.4485) | −0.21 (0.2860) | 0.9210 (0.366) | 0.29054 (0.5899) |
| L3 | −0.28 (0.1435) | −0.07 (0.7058) | 0.7927 (0.436) | 0.07672 (0.7818) |
| L4 | −0.2 (0.2926) | 0.00 (0.9827) | 0.7670 (0.451) | 0.01315 (0.9087) |
| L5 | −0.24 (0.2139) | 0.01 (0.9725) | 0.5114 (0.614) | 0.01817 (0.8928) |
| MLS | −0.23 (0.2352) | −0.06 (0.7677) | 0.7887 (0.438) | 0.27898 (0.5974) |